Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Pharmaust Limited ( (AU:NUZ) ) has provided an update.
Neurizon Therapeutics Limited announced a change in the interest of its director, Sergio Duchini. Mr. Duchini has been granted 960,000 unlisted options, exercisable at $0.20 each, with an expiration date of June 30, 2032. This move, approved at the company’s Annual General Meeting, reflects the company’s commitment to align management interests with shareholder value, potentially impacting the company’s governance and signaling confidence in its future prospects.
More about Pharmaust Limited
YTD Price Performance: 6.67%
Average Trading Volume: 5,132
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €43.14M
For a thorough assessment of NUZ stock, go to TipRanks’ Stock Analysis page.
